To clarify whether hepatic steatosis-related GCKR gene variants correlate with the histological progression of NAFLD, Speliotes et al. (25) genotyped 592 patients with biopsy-confirmed NAFLD from the NASH Clinical Research Network. This evidence concerns the gene GCKR and metabolic dysfunction-associated steatohepatitis.